A new pill for metastatic pancreatic cancer has shown promise in improving survival rates, with some reports suggesting it can double survival time. The pill, which targets a specific mutation, has been found to be more effective than traditional IV chemotherapy in some cases. The development of this drug, along with another new medication, may offer new hope for patients with one of the deadliest forms of cancer.